Table 2 Radiological and biological best overall response in patients with measurable disease at baseline (treatment group)
Pt-S (n = 4) | Pt-R (n = 24) | Total (n = 28) | |
|---|---|---|---|
Radiological Best Overall Response | |||
Investigator-assessed RECIST ORR | 1 (25%) | 3 (13%) | 4 (14%) |
Complete response | 0 | 0 | 0 |
Partial response | 1 (25%) | 3 (13%) | 4 (14%) |
Stable disease | 2 (50%) | 2 (8%) | 4 (14%) |
Progressive disease | 1 (25%) | 10 (42%) | 11 (39%) |
Not assessable | 0 | 9 (38%) | 9 (32%) |
Biological best overall response | |||
Response | 1 (25%) | 2 (8%) | 3 (11%) |
Stabilisation | 1 (25%) | 6 (25%) | 7 (25%) |
Progression | 1 (25%) | 5 (21%) | 6 (21%) |
Not assessable | 1 (25%) | 11 (46%) | 12 (43%) |